These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


292 related items for PubMed ID: 26798982

  • 1. Opioid antagonists in broadly defined behavioral addictions: a narrative review.
    Piquet-Pessôa M, Fontenelle LF.
    Expert Opin Pharmacother; 2016; 17(6):835-44. PubMed ID: 26798982
    [Abstract] [Full Text] [Related]

  • 2. Naltrexone in the Treatment of Broadly Defined Behavioral Addictions: A Review and Meta-Analysis of Randomized Controlled Trials.
    Mouaffak F, Leite C, Hamzaoui S, Benyamina A, Laqueille X, Kebir O.
    Eur Addict Res; 2017; 23(4):204-210. PubMed ID: 28877518
    [Abstract] [Full Text] [Related]

  • 3. Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling.
    Grant JE, Potenza MN, Hollander E, Cunningham-Williams R, Nurminen T, Smits G, Kallio A.
    Am J Psychiatry; 2006 Feb; 163(2):303-12. PubMed ID: 16449486
    [Abstract] [Full Text] [Related]

  • 4. A case of kleptomania and compulsive sexual behavior treated with naltrexone.
    Grant JE, Kim SW.
    Ann Clin Psychiatry; 2001 Dec; 13(4):229-31. PubMed ID: 11958364
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Opioid antagonists in the treatment of impulse-control disorders.
    Kim SW.
    J Clin Psychiatry; 1998 Apr; 59(4):159-64. PubMed ID: 9590665
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical uses of naltrexone: a review of the evidence.
    Modesto-Lowe V, Van Kirk J.
    Exp Clin Psychopharmacol; 2002 Aug; 10(3):213-27. PubMed ID: 12233982
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The relationship of DSM-IV pathological gambling to compulsive buying and other possible spectrum disorders: results from the Iowa PG family study.
    Black DW, Coryell W, Crowe R, Shaw M, McCormick B, Allen J.
    Psychiatry Res; 2015 Mar 30; 226(1):273-6. PubMed ID: 25660732
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Study of impulse control disorders among women presenting nicotine dependence.
    Lejoyeux M, Kerner L, Thauvin I, Loi S.
    Int J Psychiatry Clin Pract; 2006 Mar 30; 10(4):241-6. PubMed ID: 24941141
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Nalmefene for the treatment of alcohol use disorders: recent data and clinical potential.
    Soyka M.
    Expert Opin Pharmacother; 2016 Mar 30; 17(4):619-26. PubMed ID: 26810044
    [Abstract] [Full Text] [Related]

  • 18. DSM-5 obsessive-compulsive and related disorders: clinical implications of new criteria.
    Van Ameringen M, Patterson B, Simpson W.
    Depress Anxiety; 2014 Jun 30; 31(6):487-93. PubMed ID: 24616177
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.